Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W J Strachan

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
Diabetes Care|November 5, 2013
Genetic and environmental determinants of dimethylarginines and association with cardiovascular disease in patients with type 2 diabetesMaike Anderssohn, Stela McLachlan, Nicole Lüneburg, et al.
European Thyroid Journal|March 29, 2021
Medullary Thyroid Cancer Patient's Assessment of Quality of Life Tools: Results from the QaLM StudyLaura Moss, Catrin Cox, Jonathan Wadsley, et al.
European Journal of Endocrinology|March 13, 2012
Glucocorticoid treatment and impaired mood, memory and metabolism in people with diabetes: the Edinburgh Type 2 Diabetes StudyRebecca M Reynolds, Javier Labad, Alison V Sears, et al.
Diabetologia|May 22, 2017
Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetesSara J Jenks, Bryan R Conway, Stela McLachlan, et al.
Diabetes Care|October 10, 2013
Severe hypoglycemia and cognitive decline in older people with type 2 diabetes: the Edinburgh type 2 diabetes studyInsa Feinkohl, Phyu Phyu Aung, Marketa Keller, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 9, 2025
Impact of Omnipod 5 automated insulin delivery on continuous glucose monitoring metrics and predictors of improvement in time in rangeRoland H Stimson, Mark W J Strachan, Shareen Forbes, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 1, 2020
Impact of routine clinic measurement of serum C-peptide in people with a clinician-diagnosis of type 1 diabetesEvgenia Foteinopoulou, Catriona A L Clarke, Rebecca J Pattenden, et al.
The Journal of Clinical Endocrinology and Metabolism|February 5, 2010
Elevated fasting plasma cortisol is associated with ischemic heart disease and its risk factors in people with type 2 diabetes: the Edinburgh type 2 diabetes studyRebecca M Reynolds, Javier Labad, Mark W J Strachan, et al.
Diabetologia|October 30, 2025
Persistent C-peptide secretion is associated with favourable CGM metrics in adults with type 1 diabetesRoland H Stimson, Anna R Dover, Catriona Clarke, et al.
Diabetes|August 28, 2010
Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes StudyJie Ding, Mark W J Strachan, Rebecca M Reynolds, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Diabetes Care|November 5, 2013
Genetic and environmental determinants of dimethylarginines and association with cardiovascular disease in patients with type 2 diabetesMaike Anderssohn, Stela McLachlan, Nicole Lüneburg, et al.
European Thyroid Journal|March 29, 2021
Medullary Thyroid Cancer Patient's Assessment of Quality of Life Tools: Results from the QaLM StudyLaura Moss, Catrin Cox, Jonathan Wadsley, et al.
European Journal of Endocrinology|March 13, 2012
Glucocorticoid treatment and impaired mood, memory and metabolism in people with diabetes: the Edinburgh Type 2 Diabetes StudyRebecca M Reynolds, Javier Labad, Alison V Sears, et al.
Diabetologia|May 22, 2017
Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetesSara J Jenks, Bryan R Conway, Stela McLachlan, et al.
Diabetes Care|October 10, 2013
Severe hypoglycemia and cognitive decline in older people with type 2 diabetes: the Edinburgh type 2 diabetes studyInsa Feinkohl, Phyu Phyu Aung, Marketa Keller, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 9, 2025
Impact of Omnipod 5 automated insulin delivery on continuous glucose monitoring metrics and predictors of improvement in time in rangeRoland H Stimson, Mark W J Strachan, Shareen Forbes, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 1, 2020
Impact of routine clinic measurement of serum C-peptide in people with a clinician-diagnosis of type 1 diabetesEvgenia Foteinopoulou, Catriona A L Clarke, Rebecca J Pattenden, et al.
The Journal of Clinical Endocrinology and Metabolism|February 5, 2010
Elevated fasting plasma cortisol is associated with ischemic heart disease and its risk factors in people with type 2 diabetes: the Edinburgh type 2 diabetes studyRebecca M Reynolds, Javier Labad, Mark W J Strachan, et al.
Diabetologia|October 30, 2025
Persistent C-peptide secretion is associated with favourable CGM metrics in adults with type 1 diabetesRoland H Stimson, Anna R Dover, Catriona Clarke, et al.
Diabetes|August 28, 2010
Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes StudyJie Ding, Mark W J Strachan, Rebecca M Reynolds, et al.
Pageof 11